Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice.

Lowery JJ, Raymond TJ, Giuvelis D, Bidlack JM, Polt R, Bilsky EJ.

J Pharmacol Exp Ther. 2011 Mar;336(3):767-78. doi: 10.1124/jpet.110.172866. Epub 2010 Nov 30.

2.

Structure and function of the blood-brain barrier.

Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ.

Neurobiol Dis. 2010 Jan;37(1):13-25. doi: 10.1016/j.nbd.2009.07.030. Epub 2009 Aug 5. Review.

PMID:
19664713
3.

Glycosylation improves the central effects of DAMGO.

Lowery JJ, Yeomans L, Keyari CM, Davis P, Porreca F, Knapp BI, Bidlack JM, Bilsky EJ, Polt R.

Chem Biol Drug Des. 2007 Jan;69(1):41-7.

PMID:
17313456
4.

The blood-brain barrier as a regulatory interface in the gut-brain axes.

Banks WA.

Physiol Behav. 2006 Nov 30;89(4):472-6. Epub 2006 Aug 10. Review.

PMID:
16904139
5.

New prospects for glycopeptide based analgesia: glycoside-induced penetration of the blood-brain barrier.

Dhanasekaran M, Polt R.

Curr Drug Deliv. 2005 Jan;2(1):59-73. Review.

PMID:
16305409
6.

Glycosylated neuropeptides: a new vista for neuropsychopharmacology?

Polt R, Dhanasekaran M, Keyari CM.

Med Res Rev. 2005 Sep;25(5):557-85. Review.

PMID:
16075406
7.

Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides.

Elmagbari NO, Egleton RD, Palian MM, Lowery JJ, Schmid WR, Davis P, Navratilova E, Dhanasekaran M, Keyari CM, Yamamura HI, Porreca F, Hruby VJ, Polt R, Bilsky EJ.

J Pharmacol Exp Ther. 2004 Oct;311(1):290-7. Epub 2004 May 27.

8.

The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats.

JANSSEN PA, NIEMEGEERS CJ, DONY JG.

Arzneimittelforschung. 1963 Jun;13:502-7. No abstract available.

PMID:
13957426
9.

Glycopeptide-membrane interactions: glycosyl enkephalin analogues adopt turn conformations by NMR and CD in amphipathic media.

Palian MM, Boguslavsky VI, O'Brien DF, Polt R.

J Am Chem Soc. 2003 May 14;125(19):5823-31.

PMID:
12733923
10.

Designing peptide receptor agonists and antagonists.

Hruby VJ.

Nat Rev Drug Discov. 2002 Nov;1(11):847-58. Review.

PMID:
12415245
11.

Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor.

Parkhill AL, Bidlack JM.

Eur J Pharmacol. 2002 Sep 20;451(3):257-64.

PMID:
12242086
12.

Variants of 3(10)-helices in proteins.

Pal L, Basu G, Chakrabarti P.

Proteins. 2002 Aug 15;48(3):571-9.

PMID:
12112680
13.

Converting a peptide into a drug: strategies to improve stability and bioavailability.

Adessi C, Soto C.

Curr Med Chem. 2002 May;9(9):963-78. Review.

PMID:
11966456
14.

Amide proton temperature coefficients as hydrogen bond indicators in proteins.

Cierpicki T, Otlewski J.

J Biomol NMR. 2001 Nov;21(3):249-61.

PMID:
11775741
15.

Prediction of tight turns and their types in proteins.

Chou KC.

Anal Biochem. 2000 Nov 1;286(1):1-16. Review.

PMID:
11038267
16.

Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability.

Bilsky EJ, Egleton RD, Mitchell SA, Palian MM, Davis P, Huber JD, Jones H, Yamamura HI, Janders J, Davis TP, Porreca F, Hruby VJ, Polt R.

J Med Chem. 2000 Jun 29;43(13):2586-90.

PMID:
10891118
17.

On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database.

Apweiler R, Hermjakob H, Sharon N.

Biochim Biophys Acta. 1999 Dec 6;1473(1):4-8. Review.

PMID:
10580125
18.

Phosphorylation of enkephalins enhances their proteolytic stability.

Dass C, Mahalakshmi P.

Life Sci. 1996;58(13):1039-45.

PMID:
8622556
19.

Conformational analysis of mu-selective [D-Ala2,MePhe4]enkephalins.

Penkler LJ, Van Rooyen PH, Wessels PL.

Int J Pept Protein Res. 1993 Mar;41(3):261-74.

PMID:
8385078
20.

Supplemental Content

Support Center